Mary G. Sorci-Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary G. Sorci-Thomas has a total of 352 co-authors. Here are the top co-authors by number of shared publications:
Michael J. Thomas
Division of Endocrinology and Molecular Medicine, Department of Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Research Center, Division of Endocrinology and Molecular Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
31 shared publicationsShaila Bhat
§Departments of Pathology and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232
12 shared publicationsManal Zabalawi
Section of Molecular Medicine, and Biochemistry, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC
11 shared publicationsHao Xu
Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, WI
6 shared publicationsBrian Fulp
Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina 27101, United States
5 shared publicationsMichael P. Samuel
§Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina
5 shared publications
Latest Publications
- Open Access
Adipocyte Expression of O-Glycoprotein Procollagen C-Endopeptidase Enhancer Protein 2 (PCPE2): Mechanisms Linking Fibrosis and Beiging of White Adipose Tissue
Background: Procollagen C-endopeptidase enhancer protein 2 (Pcpe2) has been primarily investigated in collagen processing during wound healing and is assumed to function similarly to Pcpe1 in the extracellular matrix (ECM). Our studies suggest that Pcpe2 has unique structural and functional features not shared with Pcpe1. Methods: To study the role of Pcpe2 in adipose tissue remodeling, we created adipose tissue-specific knockout of Pcpe2 (TgAd+Pcpe2KO) and adipose tissue-specific Pcpe2 overexpressing (TgAd+Pcpe2Ox) mice and performed in vivo and ex vivo experiments. Results: We show that TgAd+Pcpe2KO mice are resistant to WD-induced obesity and exhibit reductions in body and fat pad mass. Promethion cage studies showed no significant differences in lean mass or food intake, yet WD-fed TgAd+Pcpe2KO mice exhibited significantly higher energy expenditure than negative Cre littermate controls. WD-fed TgAd+Pcpe2KO mice also showed reduced plasma glucose and lipoprotein lipid concentrations compared to controls. While markers of adipose tissue inflammation were reduced in WD-fed TgAd+Pcpe2KO mice. Examination of mature adipocytes from white adipose tissue showed that WD consumption greatly stimulated Pcpe2 expression, while no change in Pcpe2 expression in the stromal vascular cells was noted. However, in VAT precursor cells (PCs), the CD140b+ population showed a shift from fibroadipogenic precursors towards adipocyte PCs in TgAd+Pcpe2KO mice. This shift in PCs may account for the attenuation of local inflammation and fibrosis in the absence of Pcpe2. Ex vivo differentiation of adipose PCs showed that loss of Pcpe2 enhanced adipocyte differentiation, reducing TGFβ-like signaling via pSmad2/3, and increasing mitochondrial function. Furthermore, unlike Pcpe1, Pcpe2 contains a mucin-like linker domain with nine sites of O-linked glycosylation which may regulate receptor signaling at the plasma membrane. Conclusions: Our results show the ECM O-glycoprotein Pcpe2 is a robust marker of unhealthy adipose tissue expansion in humans and mice and contributes to inflammation and fibrosis associated with WD-induced obesity.
Open AccessAdipocyte Expression of O-Glycoprotein Procollagen C-Endopeptidase Enhancer Protein 2 (PCPE2): Mechanisms Linking Fibrosis and Beiging of White Adipose Tissue
Background: Procollagen C-endopeptidase enhancer protein 2 (Pcpe2) has been primarily investigated in collagen processing during wound healing and is assumed to function similarly to Pcpe1 in the extracellular matrix (ECM). Our studies suggest that Pcpe2 has unique structural and functional features not shared with Pcpe1. Methods: To study the role of Pcpe2 in adipose tissue remodeling, we created adipose tissue-specific knockout of Pcpe2 (TgAd+Pcpe2KO) and adipose tissue-specific Pcpe2 overexpressing (TgAd+Pcpe2Ox) mice and performed in vivo and ex vivo experiments. Results: We show that TgAd+Pcpe2KO mice are resistant to WD-induced obesity and exhibit reductions in body and fat pad mass. Promethion cage studies showed no significant differences in lean mass or food intake, yet WD-fed TgAd+Pcpe2KO mice exhibited significantly higher energy expenditure than negative Cre littermate controls. WD-fed TgAd+Pcpe2KO mice also showed reduced plasma glucose and lipoprotein lipid concentrations compared to controls. While markers of adipose tissue inflammation were reduced in WD-fed TgAd+Pcpe2KO mice. Examination of mature adipocytes from white adipose tissue showed that WD consumption greatly stimulated Pcpe2 expression, while no change in Pcpe2 expression in the stromal vascular cells was noted. However, in VAT precursor cells (PCs), the CD140b+ population showed a shift from fibroadipogenic precursors towards adipocyte PCs in TgAd+Pcpe2KO mice. This shift in PCs may account for the attenuation of local inflammation and fibrosis in the absence of Pcpe2. Ex vivo differentiation of adipose PCs showed that loss of Pcpe2 enhanced adipocyte differentiation, reducing TGFβ-like signaling via pSmad2/3, and increasing mitochondrial function. Furthermore, unlike Pcpe1, Pcpe2 contains a mucin-like linker domain with nine sites of O-linked glycosylation which may regulate receptor signaling at the plasma membrane. Conclusions: Our results show the ECM O-glycoprotein Pcpe2 is a robust marker of unhealthy adipose tissue expansion in humans and mice and contributes to inflammation and fibrosis associated with WD-induced obesity.
- 1 June 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (6)
PCPE1 and PCPE2: When Sequence Similarity Masks Functional Diversity
PCPE1 (procollagen C-endopeptidase enhancer 1) and PCPE2 are ECM (extracellular matrix) glycoproteins that lack intrinsic protease activity and regulate procollagen processing. Initially, these glycoproteins were found to be structurally related and assumed to play similar roles in enhancing collagen maturation. Recent evidence suggests that PCPE1 and PCPE2 exert both overlapping and distinct biological functions beyond collagen processing. PCPE1, first identified and shown to enhance collagen assembly in the ECM, now appears to be involved in adipose-to-liver crosstalk, angiogenesis, and fibrosis/wound healing. By comparison, PCPE2, with ≈45.6% amino acid identity (≈80.6% amino acid similarity) to PCPE1, inhibits PCPE1’s enhancement of procollagen processing while also participating in cellular plasticity, innate immune responses, and adipose tissue expansion. Together, the evidence suggests that PCPE1 and PCPE2 exhibit functional overlap but also play additional regulatory roles beyond traditional ECM remodeling.
- 1 June 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (6)
PCPE1 and PCPE2: When Sequence Similarity Masks Functional Diversity
PCPE1 (procollagen C-endopeptidase enhancer 1) and PCPE2 are ECM (extracellular matrix) glycoproteins that lack intrinsic protease activity and regulate procollagen processing. Initially, these glycoproteins were found to be structurally related and assumed to play similar roles in enhancing collagen maturation. Recent evidence suggests that PCPE1 and PCPE2 exert both overlapping and distinct biological functions beyond collagen processing. PCPE1, first identified and shown to enhance collagen assembly in the ECM, now appears to be involved in adipose-to-liver crosstalk, angiogenesis, and fibrosis/wound healing. By comparison, PCPE2, with ≈45.6% amino acid identity (≈80.6% amino acid similarity) to PCPE1, inhibits PCPE1’s enhancement of procollagen processing while also participating in cellular plasticity, innate immune responses, and adipose tissue expansion. Together, the evidence suggests that PCPE1 and PCPE2 exhibit functional overlap but also play additional regulatory roles beyond traditional ECM remodeling.
- Open Access
- 16 April 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (5) , 101041
From lipoprotein metabolism to blood clotting: Highlights of the 2025 Fredrickson lipid research conference
- 16 April 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (5) , 101041
Open AccessFrom lipoprotein metabolism to blood clotting: Highlights of the 2025 Fredrickson lipid research conference
- Open Access
- 16 October 2024
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 18 (1) , 58-69
Apolipoprotein A-I Mimetic Peptide Restores VEGF-induced Angiogenesis in Hypercholesterolemic Ischemic Heart by Reducing HDL Proinflammatory Properties
VEGF-induced angiogenesis is impaired in hypercholesterolemia. Previous studies showed that an apolipoprotein A-I(ApoA-I) mimetic peptide, D-4F, is able to reduce HDL proinflammatory index in hypercholesterolemia. Whether D-4F promotes angiogenesis in hypercholesterolemia remains unclear. Low-density lipoprotein receptor null (LDLr−/−) mice and LDLr−/−/ApoA-I−/− mice were fed with high-fat diet with or without D-4F (1mg/kg·d). C57BL/6 mice fed with normal diet served as control. The myocardial infarction was induced by ligation coronary artery, and the VEGFA-AAV 9 was injected in heart. The plasma HDL proinflammatory index, cardiac function, infarct size, and angiogenesis related signaling pathways were examined. The HDL proinflammatory index increases in hypercholesterolemic mice. VEGFA stimulates angiogenesis and improves cardiac function in ischemic heart of C57BL/6 mice, but not in hypercholesterolemic mice. D-4F reduces HDL proinflammatory index. D-4F combined with VEGFA stimulates the expression of CD31 and eNOS, activates ERK1/2, reduces infarct size, and improves cardiac function in ischemic heart in hypercholesterolemic LDLr−/− mice but not in hypercholesterolemic LDLr−/−/ApoA-I−/− mice. D-4F restores the VEGF-induced angiogenesis by reducing HDL proinflammatory properties in hypercholesterolemic ischemic heart. Graphical abstract In the presence of ApoA-I, D-4F promotes angiogenesis by restoring the anti-inflammatory properties of HDL to improve HDL function. Solid arrow:direct effect, Dotted arrow:indirect effect, Grey word:mechanisms described in previous literature
- 16 October 2024
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 18 (1) , 58-69
Open AccessApolipoprotein A-I Mimetic Peptide Restores VEGF-induced Angiogenesis in Hypercholesterolemic Ischemic Heart by Reducing HDL Proinflammatory Properties
VEGF-induced angiogenesis is impaired in hypercholesterolemia. Previous studies showed that an apolipoprotein A-I(ApoA-I) mimetic peptide, D-4F, is able to reduce HDL proinflammatory index in hypercholesterolemia. Whether D-4F promotes angiogenesis in hypercholesterolemia remains unclear. Low-density lipoprotein receptor null (LDLr−/−) mice and LDLr−/−/ApoA-I−/− mice were fed with high-fat diet with or without D-4F (1mg/kg·d). C57BL/6 mice fed with normal diet served as control. The myocardial infarction was induced by ligation coronary artery, and the VEGFA-AAV 9 was injected in heart. The plasma HDL proinflammatory index, cardiac function, infarct size, and angiogenesis related signaling pathways were examined. The HDL proinflammatory index increases in hypercholesterolemic mice. VEGFA stimulates angiogenesis and improves cardiac function in ischemic heart of C57BL/6 mice, but not in hypercholesterolemic mice. D-4F reduces HDL proinflammatory index. D-4F combined with VEGFA stimulates the expression of CD31 and eNOS, activates ERK1/2, reduces infarct size, and improves cardiac function in ischemic heart in hypercholesterolemic LDLr−/− mice but not in hypercholesterolemic LDLr−/−/ApoA-I−/− mice. D-4F restores the VEGF-induced angiogenesis by reducing HDL proinflammatory properties in hypercholesterolemic ischemic heart. Graphical abstract In the presence of ApoA-I, D-4F promotes angiogenesis by restoring the anti-inflammatory properties of HDL to improve HDL function. Solid arrow:direct effect, Dotted arrow:indirect effect, Grey word:mechanisms described in previous literature
- Open Access
- 5 October 2024
- Published by Elsevier in Journal of Lipid Research
- Vol. 65 (11) , 100664
PCPE2: Expression of multifunctional extracellular glycoprotein associated with diverse cellular functions
- 5 October 2024
- Published by Elsevier in Journal of Lipid Research
- Vol. 65 (11) , 100664
Open AccessPCPE2: Expression of multifunctional extracellular glycoprotein associated with diverse cellular functions
- 1 July 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (7) , 1459-1461
Honoring the Life and Legacy of Dr David A. Dichek
- 1 July 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (7) , 1459-1461
Honoring the Life and Legacy of Dr David A. Dichek
- 1 January 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (1) , 7-11
A Century of Milestones and Breakthroughs Related to Low- and High-Density Lipoproteins
- 1 January 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (1) , 7-11
A Century of Milestones and Breakthroughs Related to Low- and High-Density Lipoproteins
- Open Access
- 14 August 2023
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 8 (1) , 1-18
High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA
Normal high-density lipoprotein (nHDL) can induce angiogenesis in healthy individuals. However, HDL from patients with coronary artery disease undergoes various modifications, becomes dysfunctional (dHDL), and loses its ability to promote angiogenesis. Here, we identified a long non-coding RNA, HDRACA, that is involved in the regulation of angiogenesis by HDL. In this study, we showed that nHDL downregulates the expression of HDRACA in endothelial cells by activating WW domain-containing E3 ubiquitin protein ligase 2, which catalyzes the ubiquitination and subsequent degradation of its transcription factor, Kruppel-like factor 5, via sphingosine 1-phosphate (S1P) receptor 1. In contrast, dHDL with lower levels of S1P than nHDL were much less effective in decreasing the expression of HDRACA. HDRACA was able to bind to Ras-interacting protein 1 (RAIN) to hinder the interaction between RAIN and vigilin, which led to an increase in the binding between the vigilin protein and proliferating cell nuclear antigen (PCNA) mRNA, resulting in a decrease in the expression of PCNA and inhibition of angiogenesis. The expression of human HDRACA in a hindlimb ischemia mouse model inhibited the recovery of angiogenesis. Taken together, these findings suggest that HDRACA is involved in the HDL regulation of angiogenesis, which nHDL inhibits the expression of HDRACA to induce angiogenesis, and that dHDL is much less effective in inhibiting HDRACA expression, which provides an explanation for the decreased ability of dHDL to stimulate angiogenesis.
- 14 August 2023
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 8 (1) , 1-18
Open AccessHigh-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA
Normal high-density lipoprotein (nHDL) can induce angiogenesis in healthy individuals. However, HDL from patients with coronary artery disease undergoes various modifications, becomes dysfunctional (dHDL), and loses its ability to promote angiogenesis. Here, we identified a long non-coding RNA, HDRACA, that is involved in the regulation of angiogenesis by HDL. In this study, we showed that nHDL downregulates the expression of HDRACA in endothelial cells by activating WW domain-containing E3 ubiquitin protein ligase 2, which catalyzes the ubiquitination and subsequent degradation of its transcription factor, Kruppel-like factor 5, via sphingosine 1-phosphate (S1P) receptor 1. In contrast, dHDL with lower levels of S1P than nHDL were much less effective in decreasing the expression of HDRACA. HDRACA was able to bind to Ras-interacting protein 1 (RAIN) to hinder the interaction between RAIN and vigilin, which led to an increase in the binding between the vigilin protein and proliferating cell nuclear antigen (PCNA) mRNA, resulting in a decrease in the expression of PCNA and inhibition of angiogenesis. The expression of human HDRACA in a hindlimb ischemia mouse model inhibited the recovery of angiogenesis. Taken together, these findings suggest that HDRACA is involved in the HDL regulation of angiogenesis, which nHDL inhibits the expression of HDRACA to induce angiogenesis, and that dHDL is much less effective in inhibiting HDRACA expression, which provides an explanation for the decreased ability of dHDL to stimulate angiogenesis.
- 1 July 2023
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 43 (7) , 1093-1095
Academic-Industry Partnerships: Transparency, Potential Conflict of Interest, and Communicating State-of-the-Art Technologies
- 1 July 2023
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 43 (7) , 1093-1095
Academic-Industry Partnerships: Transparency, Potential Conflict of Interest, and Communicating State-of-the-Art Technologies
- 1 March 2022
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (3) , 239-240
Shobha Ghosh (1958–2021)
- 1 March 2022
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (3) , 239-240
Shobha Ghosh (1958–2021)